Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Millennium presents new ALK5 inhibitors and their potential applications

Nov. 4, 2004

Preclinical and clinical data support the efficacy of DA-8159 in erectile dysfunction

Oct. 29, 2004

FDA approval for Fosrenol

Oct. 29, 2004

Dapoxetine improves latency time in patients with premature ejaculation

Oct. 28, 2004

European approval for Emselex

Oct. 28, 2004

Sertraline plus sildenafil improve sexual activity of patients with premature ejaculation

Oct. 25, 2004

Conversion of Sanctura agreement

Oct. 21, 2004

Oxytrol launched in Canada

Oct. 21, 2004

Prous Science webcasts key lecture sessions from the 27th SIU Congress

Oct. 20, 2004

Nabi begins a new clinical trial with PhosLo in ESRD

Oct. 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...